Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1048 of 1,261
  1. US 7446182

    Recombinant antibodies for the detection and neutralization of anthrax toxin

    The Board of Regents of the University of Texas System · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted
  2. US 7446199

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted
  3. US 7442718

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  4. US 7442790

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  5. US 7442372

    Delivery of therapeutic compounds to the brain and other tissues

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  6. US 7442391

    Bioactive botanical cosmetic compositions and processes for their production

    INTEGRATED BOTANICAL TECHNOLOGIES, LLC · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  7. US 7442543

    Mammalian selenoprotein differentially expressed in tumor cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  8. US 7442546

    Method of modulating inflammatory response

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  9. US 7442696

    Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses

    Ligand Pharmaceuticals Incorporated · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  10. US 7442558

    Phthalamide-lanthanide complexes for use as luminescent markers

    The Regents of the University of California · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  11. US 7442806

    Processes for preparing darifenacin hydrobromide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  12. US 7439252

    Ascomycin crystalline forms and preparation thereof

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  13. US 7438915

    Immunopotentiating effect of a Fomitella fraxinea-derived lectin on chicken immunity and resistance to coccidiosis

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  14. US 7439231

    Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof

    Provid Pharmaceuticals Inc. · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  15. US 7439249

    Inhibitors of phosphatases

    Vertex Pharmaceuticals Incorporated · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  16. US 7439265

    Irciniastatins a and b

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  17. US 7439373

    Crystalline mycophenolate sodium

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  18. US 7439399

    Processes for the preparation of atomoxetine hydrochloride

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  19. US 7439398

    Enantiomerically pure atomoxetine and tomoxetine mandelate

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  20. US 7439226

    Serine protease inhibitors

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  21. US 7439027

    Method for modulating process mediated by farnesoid activated receptors

    Ligand Pharmaceuticals Incorporated · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  22. US 7438914

    Composition and method for enhancing immune response

    ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  23. US 7438931

    Methods and compositions for the treatment of angiogenic diseases

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  24. US 7439013

    Biocompatible polymer and filter for selectively eliminating leucocytes using the same

    ASAHI KASEI KURARAY MEDICAL CO., LTD. · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.